February 7th, 2011 - ProteoGen Bio   a start-up company located at Toscana Life Sciences incubator in Siena, Italy, has incharged Singredia Life Science  to develop and manage

its international commercial strategy to fully exploit the selling potential of its products. ProteoGen Bio has developed a proprietary method to immobilize enzymes and and other proteins to a solid support to form a monolayer  where the substrate binding site is always orienteded to the solution and free for interactions, thus greatly improving processing efficiency and speed. A first range of products is a series of filter tip bioreactors for MS sample preparation based on various proteases. Paolo Soldati, the founder of Singredia Life Science, will act as the Commercial Director International for ProteoGen Bio.